In addition, Akt is activated in streptozotocin (STZ)-induced diabetic mice and increases NF-κB transcription to promote DN progression; thus, NF-κB is a major downstream target of Akt [17, 18]. This evidence concerns the gene AKT1 and liver dysplastic nodule.